Supercritical Holy Basil

by Natrium Health · liquid · 30 mL

  • On the market (NIH)
  • DSLD label 295297
  • Serving 0.5 ml (Half Dropper); amounts per 1 ml
  • 60 servings

Supercritical Holy Basil by Natrium Health lists one ingredient: 150 mg of ocimum sanctum aerial part supercritical extract per serving of 1 ml. Its current label entered the NIH Dietary Supplement Label Database on July 18, 2023.

What is in Supercritical Holy Basil?

Each row as the label prints it, per serving of 1 ml. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Supercritical Holy Basil: Supplement Facts rows against the market (DSLD label 295297, January 2026 release)
IngredientAmount% DVAmong products listing it
Ocimum sanctum Aerial Part Supercritical Extractas Caryophyllene, Eugenol12-20% Eugenol, 3-8% Caryophyllene150 mgHoly Basil in Supercritical Holy Basil against 387 products150 mg per serving; the middle half of products list 50 mg to 400 mg, the median 129 mg.150 mg

Higher than 51% of 387 products listing holy basil (median 129 mg).

Source: NIH ODS Dietary Supplement Label Database, label 295297 (entered July 18, 2023), version 9.4.0. See the label on DSLD or its label image (PDF). Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Shake well before using.
Suggested use: As a dietary supplement, take one half dropper (0.5mL) once daily.
Warnings
Disclaimer: Always consult with a qualified health physician before taking any new dietary supplements.
Warning: Do not consume more than 2mL per day.
Keep out of reach of children. Do not take this or any other supplement if under the age of 18, pregnant or nursing a baby, if you have any known or suspected medical conditions, and/or taking prescription or OTC medications.
Do not take this or any other supplement if under the age of 18, pregnant or nursing a baby, if you have any known or suspected medical conditions, and/or taking prescription or OTC medications.
Storage
Do not refrigerate.

Source: label statements in DSLD label 295297.

What else is on the label?

Other ingredients: Extra Virgin Olive Oil.

How many labels does Supercritical Holy Basil have?

One label is on file, entered on July 18, 2023.

  1. Label 295297 (current) Entered July 18, 2023 · on the market · 30 mL

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Natrium Health (distributor), Tempe, AZ. All Natrium Health products.

Where next?